{
  "slug": "untreated-infant-hip-dysplasia",
  "question": "What are the odds of disability from untreated infant hip dysplasia?",
  "quick_answer": "Roughly 1 in 5,000 US adults live with disability from hip dysplasia missed at newborn screening. Clinically significant DDH affects about 1 to 3 per 1,000 births, but screening catches nearly all of it, leaving only ~0.1 to 0.3 per 1,000 missed.\n",
  "category": "kids",
  "tags": [
    "infant"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Developmental dysplasia of the hip (DDH) is a well-known pediatric screening target, and the fear surrounding it is largely justified — but directed at the wrong node. Parents often fear the condition itself, when the actual risk is missing the diagnosis. Universal newborn screening (clinical examination at birth, selective or universal ultrasound depending on the country) catches the vast majority of cases. The residual fear is about the subset of infants whose dysplasia is missed by screening and progresses silently to early degenerative arthritis. This fear is calibrated: missed DDH has genuinely severe consequences, but the probability of missing it in a screened population is low.\n",
    "rough_estimate": "Parents often fear severe disability; the real question is the probability of missed diagnosis",
    "kind": "intuition"
  },
  "native": {
    "display": "~1-3 per 1,000 newborns have clinically significant DDH; ~0.1-0.3 per 1,000 are missed by screening",
    "numerator": 2,
    "denominator": 10000,
    "unit": "per screened birth cohort",
    "population": "US newborns undergoing standard clinical hip screening (Ortolani/Barlow)"
  },
  "normalized": {
    "lifetime_us_adult": 0.0002,
    "display": "~1 in 5,000 US adults (disability from DDH missed at screening)",
    "log_value": -3.7,
    "assumptions": "DDH prevalence ranges from 1-30 per 1,000 depending on definition and screening method. Clinically significant DDH requiring treatment affects roughly 1-3 per 1,000 live births. In populations with clinical screening (Ortolani/Barlow at birth, as in the US), the late-presentation rate (diagnosis after 3-6 months) is approximately 0.1-0.3 per 1,000. Countries using universal ultrasound screening (e.g., Austria, Germany) report even lower late-presentation rates (~0.03-0.1 per 1,000).\nAmong late-presenting cases, the probability of significant disability (early hip replacement, chronic pain, gait abnormality) is high — DDH accounts for 21-29% of total hip replacements in young adults (under 50). However, this represents cumulative decades of undiagnosed cases, not a single-year incidence.\nFor the normalized estimate: ~0.2 per 1,000 screened births experience missed DDH, and of those, roughly all develop some degree of early degenerative change. Over a US birth cohort, this yields approximately 1 in 5,000 adults living with disability attributable to missed DDH. This is a prevalence-based lifetime estimate.\n",
    "uncertainty": {
      "low": 0.0001,
      "high": 0.0005
    },
    "scope": "us_adult_lifetime"
  },
  "sources": [
    {
      "url": "https://www.ncbi.nlm.nih.gov/books/NBK563157/",
      "title": "Developmental Dysplasia of the Hip",
      "publisher": "StatPearls (NCBI Bookshelf)",
      "source_type": "reputable_reference",
      "statistic": "DDH incidence ~10 per 1,000 live births (US/UK); 4.8 per 1,000 require treatment; ~90% of neonatal hip instability resolves spontaneously",
      "excerpt": "\"The incidence of developmental dysplasia of the hip in the UK and US is approximately 10 per 1000 live births, and at birth, 1 in 1000 cases have dislocated hips.... The remaining incidence of developmental dysplasia of the hip that required some form of treatment was 4.8 per 1000 individuals.... Approximately 90% of neonatal hips with instability or mild dysplasia with a Barlow-positive hip, an alpha angle of 50° to 60°, and 50% to 60% of coverage resolve spontaneously with normal functional and radiographic outcomes.\"\n",
      "source_date": "2024-02-12",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20251114201419/https://www.ncbi.nlm.nih.gov/books/NBK563157/",
      "calculation_notes": "StatPearls provides the incidence anchor and the critical spontaneous- resolution figure: ~10 per 1,000 live births carry a DDH diagnosis, but ~90% of neonatal hip instability resolves without intervention, leaving 4.8 per 1,000 that require some form of treatment. The high spontaneous resolution rate is why some screening programs recommend watchful waiting for mild instability detected at birth.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6090187/",
      "title": "Treatment of developmental dysplasia of the hip with the Pavlik harness in children under six months of age: indications, results and failures",
      "publisher": "Journal of Children's Orthopaedics (PMC)",
      "source_type": "peer_reviewed",
      "statistic": "Pavlik harness success rate 90-96% when initiated before 3 months of age; overall success ranges 45-100%, commonly over 75%",
      "excerpt": "\"The success rate of this algorithm was reported to be 96% in infants under the age of four weeks and more than 90% in infants under the age of three months.... The overall short-, mid- or long-term success rate of the treatment ranges from 45% to 100% and it is commonly over 75%.\"\n",
      "source_date": "2018-08-01",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260503084020/https://pmc.ncbi.nlm.nih.gov/articles/PMC6090187/",
      "calculation_notes": "Omeroglou 2018 provides the treatment-success data that defines the other side of the risk equation. When DDH is detected early (under 3 months), Pavlik harness treatment succeeds in >90% of cases with very low residual dysplasia (2.81%). The key implication: the fear should not be about DDH existing, but about it being missed. Early detection + Pavlik harness is essentially curative.\n"
    },
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6771078/",
      "title": "Developmental dysplasia of the hip: update of management",
      "publisher": "EFORT Open Reviews (PMC)",
      "source_type": "peer_reviewed",
      "statistic": "DDH is the main cause of total hip replacement in young people (about 21% to 29%); relative risk for THR is 2.6 when instability exists at birth",
      "excerpt": "\"Persistent dysplasia alters hip biomechanics, overloading the articular cartilage. This overload can wear articular cartilage, leading to early OA.... DDH is the main cause of total hip replacement in young people (about 21% to 29%).... The relative risk for a THR is 2.6 when instability exists at birth in comparison with a normal hip.\"\n",
      "source_date": "2019-09-01",
      "source_accessed": "2026-04-18",
      "archive_url": "http://web.archive.org/web/20260504061521/https://pmc.ncbi.nlm.nih.gov/articles/PMC6771078/",
      "calculation_notes": "This 2019 EFORT review provides the consequence data for missed DDH. The 21-29% figure for young-adult THR attributable to DDH, and the 2.6 relative risk for THR when hip instability exists at birth, anchor the severity estimate for cases that slip through screening — establishing why a missed diagnosis carries lifelong disability rather than a self-limiting course.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Congenital heart defect (any, US births)",
      "lifetime_us_adult": 0.01
    },
    {
      "label": "Childhood leukemia (lifetime risk)",
      "lifetime_us_adult": 0.001
    },
    {
      "label": "Hip replacement before age 50 (all causes)",
      "lifetime_us_adult": 0.005
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "breech presentation",
      "multiplier": 6,
      "notes": "Breech position is the strongest single risk factor for DDH, with approximately 6-fold increased risk. AAP guidelines recommend ultrasound screening for all breech infants."
    },
    {
      "factor": "female",
      "multiplier": 4,
      "notes": "Female infants have approximately 4-fold higher DDH incidence than males, likely due to greater ligamentous laxity from maternal hormones."
    },
    {
      "factor": "family history of DDH",
      "multiplier": 5,
      "notes": "First-degree family history increases risk approximately 5-fold. Combined with female sex and breech presentation, this creates the highest-risk group."
    },
    {
      "factor": "firstborn child",
      "multiplier": 2,
      "notes": "AAP DDH clinical practice guidelines and POSNA data document approximately 2-fold higher DDH incidence in firstborn infants, attributed to tighter uterine musculature providing less room for fetal hip movement and maintaining extended hip positioning longer in utero"
    },
    {
      "factor": "oligohydramnios (low amniotic fluid) in pregnancy",
      "multiplier": 3,
      "notes": "AAP DDH guidelines identify oligohydramnios as a clinically recognized high-risk factor; reduced amniotic fluid limits fetal movement and increases mechanical forces on developing hip joints, with studies reporting approximately 3-fold higher DDH incidence"
    }
  ],
  "short_label": "Untreated infant hip dysplasia",
  "myth_framing": "calibrated",
  "outcome_severity": "serious_harm",
  "outcome_type": "chronic_illness",
  "valence": "negative",
  "caveats": "This entry normalizes to the probability of disability from MISSED DDH in a screened population. The condition itself is common (~1-3 per 1,000), but screening catches the vast majority and early treatment (Pavlik harness) is highly effective. The residual risk of disability applies to the small subset of cases missed by screening — approximately 0.1-0.3 per 1,000 in the US clinical screening model. Countries with universal ultrasound screening (Austria, Germany, Switzerland) report lower late-presentation rates. The fear is therefore calibrated: it is rational to be concerned about DDH screening quality, but the absolute probability of a screened infant developing DDH-related disability is very low. Breech presentation, female sex, and family history are the major risk factors that should trigger heightened screening vigilance.\n",
  "quality_score": {
    "d1": 3,
    "d2": 5,
    "d3": 5,
    "d4": 4,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.5,
    "scored_by": "extracted-from-transcript",
    "scored_at": "2026-04-26",
    "methodology_version": "1.0"
  },
  "reviewer": "8d-quality-review-agent",
  "last_reviewed": "2026-04-26",
  "reviewed": true,
  "generated_at": "2026-04-18",
  "image": {
    "alt": "A Pavlik harness laid flat on a clean surface, flat vector illustration in muted clinical tones."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/untreated-infant-hip-dysplasia"
}